Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-02-14 1:09 pm Purchase |
2024-12-31 | 13G | Chromocell Therapeutics Corporation CHRO |
Ikarian Capital LLC | 440,849 7.300% |
440,849![]() (New Position) |
Filing History |
2025-01-15 5:27 pm Purchase |
2024-12-13 | 13G | Chromocell Therapeutics Corporation CHRO |
Alexandra Wood (Canada) Inc. | 574,187 9.530% |
574,187![]() (New Position) |
Filing History |
2024-11-13 4:05 pm Sale |
2024-09-30 | 13G | Chromocell Therapeutics Corporation CHRO |
3i, LP | 301,000 4.990% |
-17,823![]() (-5.59%) |
Filing History |
2024-03-04 4:07 pm Purchase |
2024-02-21 | 13G | Chromocell Therapeutics Corporation CHRO |
Boswell Prayer Ltd. | 471,592 8.200% |
471,592![]() (New Position) |
Filing History |
2024-03-01 5:19 pm Purchase |
2024-02-21 | 13G | Chromocell Therapeutics Corporation CHRO |
Benuvia Operations LLC | 384,226 6.700% |
384,226![]() (New Position) |
Filing History |
2024-03-01 5:16 pm Purchase |
2024-02-21 | 13G | Chromocell Therapeutics Corporation CHRO |
Aperture Healthcare Ventures Ltd. | 444,070 7.700% |
444,070![]() (New Position) |
Filing History |
2024-03-01 5:13 pm Purchase |
2024-02-21 | 13G | Chromocell Therapeutics Corporation CHRO |
AME Equities LLC | 369,177 6.400% |
369,177![]() (New Position) |
Filing History |
2024-03-01 5:10 pm Purchase |
2024-02-21 | 13G | Chromocell Therapeutics Corporation CHRO |
Motif Pharmaceuticals Ltd. | 483,406 8.400% |
483,406![]() (New Position) |
Filing History |
2024-03-01 5:07 pm Purchase |
2024-02-21 | 13G | Chromocell Therapeutics Corporation CHRO |
3i, LP | 318,823 5.500% |
318,823![]() (New Position) |
Filing History |
2024-02-26 6:36 pm Purchase |
2024-02-15 | 13D | Chromocell Therapeutics Corporation CHRO |
Friedberg Ezra M | 545,721 9.500% |
545,721![]() (New Position) |
Filing History |